Exactech
18
8
9
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
38.9%
7 terminated/withdrawn out of 18 trials
12.5%
-74.0% vs industry average
6%
1 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Exactech Shoulder Post Market Clinical Follow-up Study
Role: lead
A Prospective Clinical Study Evaluating the Newton™ TKA Protocol
Role: collaborator
Exactech Knee Systems Post Market Clinical Follow-up
Role: lead
Comparison Between Exactech Guided Personalized Surgery (GPS) and Conventional Instrumentation of Shoulder Arthroplasty
Role: lead
Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only
Role: lead
Vantage Mobile Bearing Total Ankle System Post Market Clinical Follow-up (Outside US)
Role: lead
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Role: lead
Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up
Role: lead
Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)
Role: lead
Evaluation of Navigation-Assisted TKA Using Mechanical vs. Restricted Kinematic Alignment
Role: lead
A Post-Market Domestic (US) and International Data Collection to Assess the Truliant Knee System
Role: lead
Optetrak Knee System Post Market Clinical Follow-Up
Role: lead
Standard Total Knee Arthroplasty Using Platelet Rich Plasma (PRP)
Role: lead
Study to Assess Exactech's Guided Personalized Surgery eGPS® in Total Knee Arthroplasty
Role: lead
Optetrak Posterior Stabilized Versus Optetrak Hi-Flex
Role: lead
Platelet Rich Plasma (PRP) in Total Knee Replacement
Role: lead
Post Approval Study: NOVATION Ceramic Articulation Hip System
Role: lead
Evaluation of Radiographic and Patient Outcomes Following Lumbar Spine Fusion Using Demineralized Bone Matrix (DBM) Mixed With Autograft
Role: lead
All 18 trials loaded